April 2, 2019                AACR Annual Meeting

Abstract Number: 3038

Implications of DYRK1B kinase in ovarian cancers and utilization of DYRK1B inhibitors as a novel therapeutic strategy for ovarian cancers

Session: Drug Resistance 4

Date and Time: Tuesday April 2, 2019; 8:00 a.m. - 12:00 p.m. EDT

Location:  Exhibit Hall B; Poster Section 12; Poster Board Number 30

February, 2019             Journal of Molecular Modeling

How to design potent and selective DYRK1B inhibitors? Molecular modeling study.

December 1, 2018        ASH Annual Meeting

The Chromosome 21 Kinase DYRK1A and Its Substrate FOXO1 Constitute a Novel Therapeutic Pathway in B-ALL.

April 4, 2017                AACR Annual Meeting

​

DYRK1B inhibitors prevent pharmacologic quiescence and sensitize lung cancers to EGFR inhibitors.

January 11, 2016          8th Annual BIOTECH Showcase

Oral presentation

Date and Time:  January 13th 2016 8AM

Location: The Parc 55 San Francisco Track A